These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36821582)

  • 1. Mucosal and systemic neutralizing antibodies to norovirus induced in infant mice orally inoculated with recombinant rotaviruses.
    Kawagishi T; Sánchez-Tacuba L; Feng N; Costantini VP; Tan M; Jiang X; Green KY; Vinjé J; Ding S; Greenberg HB
    Proc Natl Acad Sci U S A; 2023 Feb; 120(9):e2214421120. PubMed ID: 36821582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of Recombinant Rotaviruses Expressing Human Norovirus Capsid Proteins.
    Philip AA; Patton JT
    J Virol; 2022 Nov; 96(22):e0126222. PubMed ID: 36314817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of the VP4 Attachment Protein in Rotavirus Host Range Restriction in an
    Sánchez-Tacuba L; Kawagishi T; Feng N; Jiang B; Ding S; Greenberg HB
    J Virol; 2022 Aug; 96(15):e0055022. PubMed ID: 35862708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice.
    Tamminen K; Lappalainen S; Huhti L; Vesikari T; Blazevic V
    PLoS One; 2013; 8(7):e70409. PubMed ID: 23922988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
    Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V
    Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus NSP1 Contributes to Intestinal Viral Replication, Pathogenesis, and Transmission.
    Hou G; Zeng Q; Matthijnssens J; Greenberg HB; Ding S
    mBio; 2021 Dec; 12(6):e0320821. PubMed ID: 34903043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.
    Lappalainen S; Pastor AR; Tamminen K; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
    Hum Vaccin Immunother; 2014; 10(7):2039-47. PubMed ID: 25424814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse Genetics Approach for Developing Rotavirus Vaccine Candidates Carrying VP4 and VP7 Genes Cloned from Clinical Isolates of Human Rotavirus.
    Kanai Y; Onishi M; Kawagishi T; Pannacha P; Nurdin JA; Nouda R; Yamasaki M; Lusiany T; Khamrin P; Okitsu S; Hayakawa S; Ebina H; Ushijima H; Kobayashi T
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33087468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Species a Rotavirus Reverse Genetics to Engineer Chimeric Viruses Expressing SARS-CoV-2 Spike Epitopes.
    Diebold O; Gonzalez V; Venditti L; Sharp C; Blake RA; Tan WS; Stevens J; Caddy S; Digard P; Borodavka A; Gaunt E
    J Virol; 2022 Jul; 96(14):e0048822. PubMed ID: 35758692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Optimized Reverse Genetics System Suitable for Efficient Recovery of Simian, Human, and Murine-Like Rotaviruses.
    Sánchez-Tacuba L; Feng N; Meade NJ; Mellits KH; Jaïs PH; Yasukawa LL; Resch TK; Jiang B; López S; Ding S; Greenberg HB
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32759316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.
    Feng N; Burns JW; Bracy L; Greenberg HB
    J Virol; 1994 Dec; 68(12):7766-73. PubMed ID: 7966566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Rotaviruses Rescued by Reverse Genetics Reveal the Role of NSP5 Hyperphosphorylation in the Assembly of Viral Factories.
    Papa G; Venditti L; Arnoldi F; Schraner EM; Potgieter C; Borodavka A; Eichwald C; Burrone OR
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis.
    Blazevic V; Lappalainen S; Nurminen K; Huhti L; Vesikari T
    Vaccine; 2011 Oct; 29(45):8126-33. PubMed ID: 21854823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model.
    Yuan L; Saif LJ
    Vet Immunol Immunopathol; 2002 Sep; 87(3-4):147-60. PubMed ID: 12072229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse Genetics System for a Human Group A Rotavirus.
    Kawagishi T; Nurdin JA; Onishi M; Nouda R; Kanai Y; Tajima T; Ushijima H; Kobayashi T
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31645445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Stable Rotavirus Reporter Expression Systems.
    Kanai Y; Kawagishi T; Nouda R; Onishi M; Pannacha P; Nurdin JA; Nomura K; Matsuura Y; Kobayashi T
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30541830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Recombinant Rotavirus Expressing NSP3-UnaG Fusion Protein by a Simplified Reverse Genetics System.
    Philip AA; Perry JL; Eaton HE; Shmulevitz M; Hyser JM; Patton JT
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31597761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-energy malnutrition alters IgA responses to rotavirus vaccination and infection but does not impair vaccine efficacy in mice.
    Maier EA; Weage KJ; Guedes MM; Denson LA; McNeal MM; Bernstein DI; Moore SR
    Vaccine; 2013 Dec; 32(1):48-53. PubMed ID: 24200975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of rotavirus vaccines in small animal models.
    Ciarlet M; Conner ME
    Methods Mol Med; 2000; 34():147-87. PubMed ID: 21318860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesicular stomatitis virus as a vector to deliver virus-like particles of human norovirus: a new vaccine candidate against an important noncultivable virus.
    Ma Y; Li J
    J Virol; 2011 Mar; 85(6):2942-52. PubMed ID: 21228240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.